Chlorhexidine for Prevention of Catheter-Associated Urinary Tract Infections: The Totality of Evidence - Author's Reply
| avondale-bepress.context-key | 16934926 | |
| avondale-bepress.submission-path | nh_papers/195 | |
| avondale.affiliate | Mitchell, Brett; 0000-0003-4220-8291 | |
| avondale.department | Lifestyle Medicine and Health Research Centre | |
| avondale.faculty | Nursing | |
| avondale.reporting.version | Published Version | |
| dc.contributor.author | Collignon, Peter | |
| dc.contributor.author | Koerner, Jane | |
| dc.contributor.author | Graves, Nicholas | |
| dc.contributor.author | Gardner, Anne | |
| dc.contributor.author | Fasugba, Oyebola | |
| dc.contributor.author | Cheng, Allen | |
| dc.contributor.author | Mitchell, Brett G. | |
| dc.date.accessioned | 2023-11-01T00:29:50Z | |
| dc.date.available | 2023-11-01T00:29:50Z | |
| dc.date.issued | 2019-08-01 | |
| dc.date.submitted | 2020-03-19T16:54:45Z | |
| dc.identifier.citation | <p>Mitchell, B. G., Cheng, A. C., Fasugba, O., Gardner, A., Graves, N., Koerner, J., & Collignon, P. (2019). Chlorhexidine for prevention of catheter-associated urinary tract infections: The totality of evidence-Author's reply [Correspondence]. <em>The Lancet Infectious Diseases, 19</em>(8), 808-809. doi:10.1016/S1473-3099(19)30349-4</p> | |
| dc.identifier.doi | https://doi.org/10.1016/S1473-3099(19)30349-4 | |
| dc.identifier.issn | 1473-3099 | |
| dc.identifier.uri | https://research.avondale.edu.au/handle/1897/16934926 | |
| dc.language.iso | en_us | |
| dc.relation.ispartof | The Lancet Infectious Diseases | |
| dc.rights | <p>Due to copyright restrictions this article is unavailable for download.</p> <p>© 2019 Elsevier Ltd. All rights reserved.</p> | |
| dc.title | Chlorhexidine for Prevention of Catheter-Associated Urinary Tract Infections: The Totality of Evidence - Author's Reply | |
| dc.type | Journal Article |